Assyro AI

Orange Book product · Generic (ANDA)

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Generic (ANDA)ANDA 075231TE ABRX LGM PHARMA

At a glance

Nov 30, 2001

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 30, 2001

    24 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Strength

325MG;50MG;40MG;30MG

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

ANDA 075231

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.